Sign up to save your podcasts
Or
Share PubReading [7] - Modified nucleic acids: replication, evolution, and next-generation therapeutics - K. Duffy, S. Arangundy-Franklin and P. Holliger
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
PubReading [7] - Modified nucleic acids: replication, evolution, and next-generation therapeutics - K. Duffy, S. Arangundy-Franklin and P. Holliger
Modified nucleic acids, also called xeno nucleic acids (XNAs), offer a variety of advantages for biotechnological applications and address some of the limitations of first-generation nucleic acid therapeutics. Indeed, several therapeutics based on modified nucleic acids have recently been approved and many more are under clinical evaluation. XNAs can provide increased biostability and furthermore are now increasingly amenable to in vitro evolution, accelerating lead discovery. Here, we review the most recent discoveries in this dynamic field with a focus on progress in the enzymatic replication and functional exploration of XNAs. K. Duffy, S. Arangundy-Franklin and P. Holliger -doi.org/10.1186/s12915-020-00803-6 - 2020
View all episodes
By Mando MouradModified nucleic acids, also called xeno nucleic acids (XNAs), offer a variety of advantages for biotechnological applications and address some of the limitations of first-generation nucleic acid therapeutics. Indeed, several therapeutics based on modified nucleic acids have recently been approved and many more are under clinical evaluation. XNAs can provide increased biostability and furthermore are now increasingly amenable to in vitro evolution, accelerating lead discovery. Here, we review the most recent discoveries in this dynamic field with a focus on progress in the enzymatic replication and functional exploration of XNAs. K. Duffy, S. Arangundy-Franklin and P. Holliger -doi.org/10.1186/s12915-020-00803-6 - 2020
More shows like PubReading
View all
ESGfitness
33 Listeners